Area of research
Endocrinology, Diabetes and Metabolism · Surgery
Research interest
Research interests include Medicine, Neuroendocrine tumors, Internal medicine, Pituitary tumors, Everolimus, and Guideline.
Parathyroid carcinoma: New insights
Advances in the management of parathyroid carcinoma
Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants
Diagnosis and management of parathyroid carcinoma: a state-of-the-art review
Impact of the PI3K-alpha inhibitor alpelisib on everolimus resistance and somatostatin receptor expression in an orthotopic pancreatic NEC xenograft mouse model
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance
The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?
Consensus on diagnosis and management of Cushing's disease: a guideline update
White Rose Research Online (University of Leeds, The University of Sheffield, University of York) 2021cited by 351position: middle
International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification
Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?
Corticotroph tumor progression after bilateral adrenalectomy (Nelson’s syndrome): systematic review and expert consensus recommendations
Can COVID‐19 immunisation cause subacute thyroiditis?
COVID‐19‐related thyroiditis: A novel disease entity?
Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy
Metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution
Synergistic Highly Potent Targeted Drug Combinations in Different Pheochromocytoma Models Including Human Tumor Cultures
Colonic Cancer and Acromegaly
Unmet Needs in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)
Aggressive and malignant pituitary tumours: state-of-the-art
The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification
Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors
GSK3α/β: A Novel Therapeutic Target for Neuroendocrine Tumors
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Appendiceal neuroendocrine neoplasms: diagnosis and management